MAIA Biotechnology Achieves Patient Enrollment Milestones in Ongoing Phase 2 and Pivotal Phase 3 Clinical Trials in Non-Small Cell Lung Cancer
October 7, 2026
Technology
-
-
Railtown AI Launches Native Swift Agent Development Technology for the Next Generation of Agentic Applications
October 6, 2026
-
Everspin Technologies to Ring Opening Bell in Celebration of 10-Year Nasdaq Anniversary
October 6, 2026
-
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
October 6, 2026
-
ZenaTech Letter to Shareholders Outlines 316% Q2 Revenue Growth and Seventh Consecutive Quarter of Sequential Growth
October 1, 2026
-
PharmaTher Enters into Exclusive North American Distribution Agreement with Craft Health for CraftMake(TM) Pharmaceutical 3D Printing Platform
October 1, 2026
-
AI Transforms Revenue and Billing Software, ISG says
September 30, 2026
-
SEALSQ Highlights Its Subsidiary IC’Alps’ Low-Power, Secure ASIC Design Expertise for Implantable and Connected Medical Devices
September 30, 2026
-
Oregon Department of Transportation Selects Rekor Command® to Deliver Safety Alerts Directly to Drivers Statewide
September 30, 2026
-
ZenaTech Reports 425% First Half and 316% Second-Quarter Year-Over-Year Revenue Growth as Drone as a Service Segment Continues to Scale
September 29, 2026
-
Netlist Files New ITC Action Against Micron Technology, Inc. Involving HBM Patents for AI Computing
September 29, 2026
-
Edison Issues Report on iQSTEL (IQST)
September 29, 2026
-
Unicycive Therapeutics Announces Resubmission of New Drug Application for Oxylanthanum Carbonate
September 29, 2026
-
Veritone Partners with ATP Media to Unlock New Revenue from Tennis’s Greatest Moments
September 29, 2026
-
Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies
September 22, 2026
-
Aurora Mobile’s GPTBots.ai Integrates Jev – Two Layers of AI, One Enterprise Platform
September 22, 2026